TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/8/24 16:43 | 11/4/23 | KROS | Keros Therapeutics, Inc. | Health | Drug | Pharmaceutical Preparations | Regnante Keith | MA | O | CFO | S.d | -1,812 | 45.29 | 0 | -40 | -100 | 0 | D | |||||||||||||||
6/12/23 16:13 | 6/8/23 | KROS | Keros Therapeutics, Inc. | Health | Drug | Pharmaceutical Preparations | Regnante Keith | MA | O | CFO | S.dm | -1,864 | 46.61 | 0 | -40 | -100 | 0 | D | |||||||||||||||
2/21/19 19:54 | 2/19/19 | WVE | Wave Life Sciences Ltd. | U0 | Health | Drug | Pharmaceutical Preparations | Regnante Keith | MA | O | CFO | S | -48 | 36.84 | 0 | -1 | -8 | 16 | D | ||||||||||||||
9/26/18 18:59 | 9/24/18 | WVE | Wave Life Sciences Ltd. | U0 | Health | Drug | Pharmaceutical Preparations | Regnante Keith | MA | O | CFO | S.d | -1,623 | 55.00 | 0 | -30 | -63 | 17 | D | ||||||||||||||
2/21/18 19:16 | 2/16/18 | WVE | Wave Life Sciences Ltd. | U0 | Health | Drug | Pharmaceutical Preparations | Regnante Keith | MA | O | CFO | S | -16 | 51.85 | 0 | 0 | -2 | 17 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |